医院药事

医疗机构受赠药品分析及管理工作探讨

展开
  • 华中科技大学同济医学院附属同济医院,武汉 430030
余恒毅,主管药师,从事医院药事管理相关工作;E-mail:yuhengyichina@163.com
刘东,主任药师,从事医院药事管理工作;E-mail:ld2069@outlook.com

收稿日期: 2020-06-12

  网络出版日期: 2024-08-01

基金资助

“重大新药创制”科技重大专项(编号 2017ZX09304022); 中央高校基本科研业务费专项资金(编号 2020kfyXGYJ050)

Analysis and Management of Donated Medicines in A Designated Medical Institution

Expand
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

Received date: 2020-06-12

  Online published: 2024-08-01

摘要

目的: 分析新冠疫情期间华中科技大学同济医院(光谷院区)接受与使用捐赠药品情况,为医疗机构受赠药品管理工作提供参考,以期加快我国药品捐赠管理规范化进程。方法: 收集2020年2月9日至2020年3月30日期间接受捐赠药品的相关数据并进行统计分析,包括来源、通用名、失效日期、数量和使用情况;通过查询世界卫生组织系统解剖学治疗学及化学分类系统、《新编简明中成药手册》、国家药品监督管理局数据系统、《国家基本药物目录》、中国医保药品目录查询系统及《新型冠状病毒肺炎诊疗手册》等数据库或文献资料识别药品属性。结果: 疫情期间,共接受85种品规的捐赠药品,其中68种(80%)为企业捐赠,是受赠药品的主要来源。受赠药品品种适宜性方面,55种(64.7%)被视为适宜捐赠,30种(35.3%)不适宜捐赠。剩余效期方面,77种(90.6%)的剩余效期≥12个月,6种(7.0%)介于6至11个月之间,但有2种(2.4%)中药免煎颗粒未注明失效日期。使用率方面,8种(9.4%)的总使用率达100%,25种(29.4%)介于50%至100%之间,16种(18.8%)介于10%至50%之间,17种(20%) 介于0%至10%之间,19种(22.4%)的总使用率为0%;受赠药品在患者中的使用率较低。结论: 本次受赠药品在品种适宜性、剩余效期、受赠数量和使用率方面均存在一定问题。我国应尽快制定药品捐赠指南以规范捐赠行为。医疗机构也应建立相应的管理制度,科学合理地选择与使用受赠药品。

本文引用格式

余恒毅, 陈逸天, 宗凯, 陈莉, 孙明辉, 贡雪芃, 刘东 . 医疗机构受赠药品分析及管理工作探讨[J]. 中国药事, 2021 , 35(1) : 99 -108 . DOI: 10.16153/j.1002-7777.2021.01.016

Abstract

Objective: To analyze the acceptance and use of donated medicines in Optical Valley Branch of Tongji Hospital during COVID-19, and to provide reference for the management of medicine donation in medical institutions, so as to promote the standardization of medicine donation management in China. Methods: Information about the donated medicines received by hospital between February 9, 2020 and March 30, 2020 was collected, including the source of donation, approved drug name, expiration date, quantity, and utilization. Several classification systems, databases and references were used to identify the properties of donated medicines, including the World Health Organization Systemic Anatomical Therapeutics and Chemical Classification Systems, A New Chinese Patent Medicine Manual, the data system of National Medical Products Administration, the National Essential Medicine List, China Medical Insurance Drug Catalogue Inquiry System, COVID-19 medical handbook and so on. Results: During the epidemic, a total of 85 kinds of donated medicines were received in our hospital, of which 68 (80%) were donated by enterprises, which were the main source of donated drugs. In terms of the suitability of the varieties of the donated medicines, 55 (64.7%) kinds of the donations were deemed as suitable, and 30 (35.3%) were not. In terms of the shelf-life, 77 (90.6%) kinds of the donations had a remaining shelf-life of more than 12 months, 6 (7.0%) between six and eleven months, while 2 (2.4%) kinds of the non-frying granule of traditional Chinese medicine did not have expiry date. In terms of the total utilization rate, 8 (9.4%) kinds were 100% utilized, 25 (29.4%) between 50% and 100%, 16 (18.8%) between 10% and 50%, 17 (20%) between 0% to 10%, and 19 (22.4%) were not utilized at all, and the utilization rates of donated medicines used by patients were relatively low. Conclusion: Problems existed in the field of donation appropriateness, shelf-life, donation quantity and utilization. National guidelines on medicine donation should be formulated in China lines to regulate donation behavior. Meanwhile, medical institutions should establish management system to select and use the donated medicines in a scientific and rational manner.

参考文献

[1] World Health Organization. ATC/DDD Index2020[DB/OL]. (2019-12-16)[2020-05-13]. https://www.whocc.no/atc_ddd_index/.
[2] 戴德银. 新编简明中成药手册[M]. 第4版. 郑州:河南科学技术出版社,2017.
[3] 国家药品监督管理局. 国家药品监督管理局-数据查询[DB/OL]. [2020-05-25]. http://app1.nmpa.gov.cn/datasearchcnda/face3/dir.html?type=ylqx.
[4] 中华人民共和国国家卫生健康委员会. 国家基本药物目录-2018年版[EB/OL].(2018-10-25)[2020-05-24]. http://www.nhc.gov.cn/wjw/jbywml/201810/600865149f4740eb8ebe729c426fb5d7.shtml.
[5] 中国医药保险. 医保药品目录查询系统[DB/OL].[2020-05-26]. https://www.zgylbx.com/index.php?m=content&c=index&a=lists&catid=105.
[6] 中华人民共和国国家卫生健康委员会. 新型冠状病毒肺炎诊疗方案(试行第七版)[EB/OL].(2020-03-04) [2020-06-01]. http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989/files/ce3e6945832a438eaae415350a8ce964.pdf.
[7] World Health Organization. Guidelines for medicine donations-Revised2010[EB/OL].(2011-10-01) [2020-05-01]. https://www.who.int/selection_medicines/emergencies/guidelines_medicine_donations/en/.
[8] Australian Pharmaceutical Advisory Council. Australian guidelines for drug donations to developing countries[EB/ OL].(2000-11-01)[2020-05-03]. https://apps.who.int/medicinedocs/en/m/abstract/Js20164en/.
[9] 湖北省临床药学质量控制中心. 湖北省新型冠状病毒肺炎临床用药指引(第一版)[EB/OL].(2020- 03-14)[2020-05-17]. https://mp.weixin.qq.com/s/m9SLKDNCIQw8UL60fyiLdg.
[10] 巴元明,李晓东,闵晓俊,等. 湖北省中医院新型冠状病毒肺炎中医药防治方案(第三版)[J]. 湖北中医杂志,2020,42(2):7.
[11] 广东省药品监督管理局,广东省卫生健康委员会, 广东省中医药局. 关于透解祛瘟颗粒(曾用名“肺炎1 号方”)临床使用有关规定的通知[EB/OL].(2020-02-08)[2020-05-25]. http://mpa.gd.gov.cn/zwgk/gzwj/content/post_2888223.html.
[12] 国家食品药品监督管理局. 关于印发捐赠防治非典型肺炎药品和医疗器械暂行规定的通知[EB/OL].(2003- 05-03)[2020-05-24]. http://www.nmpa.gov.cn/WS04/CL2196/323200.html.
[13] 国家食品药品监督管理局. 关于进一步加强抗震救灾捐赠药品和医疗器械监管工作的通知[EB/OL].(2010-04-15)[2020-06-15]. http://www.nmpa.gov.cn/WS04/CL2196/323768.html.
[14] 王炳丽. 受“惠”者的苦恼-SARS捐赠药品如何处理[J]. 医药世界,2004,(3):16.
[15] Mariacher GG, Mtasiwa D, Wiedenmayer K, et al.Optimizing in-kind Drug Donations for Tanzania-a Case Study[J]. INT J HEALTH PLAN M,2008,23(4): 313.
[16] 林芸竹,许群芬,刘世林,等. 从地震灾害后我院受赠药品使用情况分析探讨捐赠药品管理[J]. 中国药房, 2010,21(1):17.
[17] 肖洪涛,陈璐,邹静,等. 抗震救灾捐赠药品的科学管理[J]. 中国新药杂志,2008,(12):993.
[18] 陈鸣,童荣生. 抗震救灾捐赠药品的管理和使用引发的思考[J]. 中国药房,2009,20(22):1695.
[19] 肖洪涛,陈秋虹,陈璐,等. 接受(收)捐赠药品应遵循的原则及改进意见[J]. 中国药学杂志,2010,45(12):959.
[20] 孙佩东,李大魁. SARS带来的新问题-捐赠药品如何管理[J]. 临床药物治疗杂志,2003,(2):7.
[21] 韦少雯. “非典”药品各领风骚[J]. 中国药店,2003, (7):44.
[22] 全国人大常委会. 中华人民共和国公益事业捐赠法[EB/OL].(1999-06-28)[2020-06-30]. http://www.npc.gov.cn/wxzl/gongbao/2000-12/05/content_5004744.htm.
文章导航

/